Biogénesis Bagó

Highly Engaged Employees

Biogénesis Bagó, founded in 2006, operates within the chemicals and manufacturing sectors, specializing in advanced animal health solutions. The company maintains a diverse portfolio including high-efficacy antibiotics, specialized vaccines, and antiparasitics for livestock and companion animals. Beyond core pharmaceuticals, the organization provides essential vitamins, minerals, and environmental health solutions. By integrating rigorous research, Biogénesis Bagó addresses critical health challenges, ensuring animal well-being while supporting human health and environmental sustainability through innovative chemical applications.

The company sustains a workforce of 500-1,000 employees, fostering a culture of professional growth and technical excellence. With an operational footprint spanning 2 locations, the firm manages complex manufacturing processes to meet global demand. Meet Biogénesis Bagó's team to understand the organizational structure and the leadership driving these technical initiatives. The company’s commitment to operational efficiency is reflected in its ability to scale production while maintaining strict quality control standards across its diverse product lines, ensuring all outputs meet international regulatory requirements for safety and efficacy.

Biogénesis Bagó maintains a significant market presence, leveraging its expertise to serve clients globally. The firm’s revenue of $86.9M underscores its stable position within the competitive animal health manufacturing landscape. By focusing on B2B and B2C channels, the company distributes specialized solutions across international markets. Their dedication to innovation remains a cornerstone of their strategy, allowing them to adapt to evolving industry demands. As a key player, Biogénesis Bagó continues to prioritize sustainable health solutions, reinforcing its reputation as a reliable partner for veterinary professionals and livestock producers worldwide.